ELEVANCE HEALTH, INC. SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Other Operating Expense
ELEVANCE HEALTH, INC. (ELV) reported SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Other Operating Expense of $2.09 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense · last filed 2026-07-15
- ELEVANCE HEALTH, INC. sec schedule, 12-16, insurance companies, supplementary insurance information, other operating expense for the quarter ending 2026-06-30 was $1.03B, a 6.19% increase year-over-year.
- ELEVANCE HEALTH, INC. sec schedule, 12-16, insurance companies, supplementary insurance information, other operating expense for the quarter ending 2026-03-31 was $1.06B, a 3.71% increase year-over-year.
- ELEVANCE HEALTH, INC. sec schedule, 12-16, insurance companies, supplementary insurance information, other operating expense for the quarter ending 2025-12-31 was $946.00M, a 2.07% decline year-over-year.
- ELEVANCE HEALTH, INC. sec schedule, 12-16, insurance companies, supplementary insurance information, other operating expense for the quarter ending 2025-09-30 was $1.01B, a 9.33% increase year-over-year.
- ELEVANCE HEALTH, INC. sec schedule, 12-16, insurance companies, supplementary insurance information, other operating expense for fiscal 2025 was $3.95B, a 0.48% increase from fiscal 2024.
- ELEVANCE HEALTH, INC. sec schedule, 12-16, insurance companies, supplementary insurance information, other operating expense for fiscal 2024 was $3.93B, a 4.27% decline from fiscal 2023.
- ELEVANCE HEALTH, INC. sec schedule, 12-16, insurance companies, supplementary insurance information, other operating expense for fiscal 2023 was $4.10B, a 0.15% increase from fiscal 2022.
- ELEVANCE HEALTH, INC. sec schedule, 12-16, insurance companies, supplementary insurance information, other operating expense for fiscal 2022 was $4.10B.
| Period end | SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Other Operating Expense 3 month | SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Other Operating Expense 3 month as first filed | SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Other Operating Expense 6 month | SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Other Operating Expense 6 month as first filed | SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Other Operating Expense 9 month | SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Other Operating Expense 9 month as first filed | SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Other Operating Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.03B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-15 | $2.09B 10-Q · filed 2026-07-15 | $3.04B derived: sum of 3 quarters · filed 2026-07-15 | $4.04B derived: sum of 4 quarters · filed 2026-07-15 | |||
| 2026-03-31 | $1.06B 10-Q · filed 2026-04-22 | $2.01B derived: sum of 2 quarters · filed 2026-04-22 | $3.02B derived: sum of 3 quarters · filed 2026-04-22 | $3.98B derived: sum of 4 quarters · filed 2026-07-15 | |||
| 2025-12-31 | $946.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $1.95B derived: sum of 2 quarters · filed 2026-02-06 | $2.92B derived: sum of 3 quarters · filed 2026-07-15 | $3.95B 10-K · filed 2026-02-06 | |||
| 2025-09-30 | $1.01B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-21 | $1.98B derived: sum of 2 quarters · filed 2026-07-15 | $3.00B 10-Q · filed 2025-10-21 | $3.97B derived: sum of 4 quarters · filed 2026-07-15 | |||
| 2025-06-30 | $969.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-15 | $1.99B 10-Q · filed 2026-07-15 | $2.96B derived: sum of 3 quarters · filed 2026-07-15 | $3.88B derived: sum of 4 quarters · filed 2026-07-15 | |||
| 2025-03-31 | $1.02B 10-Q · filed 2026-04-22 | $1.99B derived: sum of 2 quarters · filed 2026-04-22 | $2.91B derived: sum of 3 quarters · filed 2026-04-22 | $3.91B derived: sum of 4 quarters · filed 2026-04-22 | |||
| 2024-12-31 | $966.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $1.89B derived: sum of 2 quarters · filed 2026-02-06 | $2.88B derived: sum of 3 quarters · filed 2026-02-06 | $3.93B 10-K · filed 2026-02-06 | |||
| 2024-09-30 | $922.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-21 | $1.92B derived: sum of 2 quarters · filed 2025-10-21 | $2.96B 10-Q · filed 2025-10-21 | $3.79B derived: sum of 4 quarters · filed 2026-02-06 | |||
| 2024-06-30 | $997.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-17 | $2.04B 10-Q · filed 2025-07-17 | $2.86B derived: sum of 3 quarters · filed 2026-02-06 | $3.93B derived: sum of 4 quarters · filed 2026-02-06 | |||
| 2024-03-31 | $1.04B 10-Q · filed 2025-04-22 | $1.87B derived: sum of 2 quarters · filed 2026-02-06 | $2.93B derived: sum of 3 quarters · filed 2026-02-06 | $4.04B derived: sum of 4 quarters · filed 2026-02-06 | |||
| 2023-12-31 | $823.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $1.89B derived: sum of 2 quarters · filed 2026-02-06 | $3.00B derived: sum of 3 quarters · filed 2026-02-06 | $4.10B 10-K · filed 2026-02-06 | |||
| 2023-09-30 | $1.07B 10-Q · filed 2023-10-18 | $2.18B derived: sum of 2 quarters · filed 2023-10-18 | $3.28B 10-Q · filed 2024-10-17 | $4.21B derived: sum of 4 quarters · filed 2025-02-20 | |||
| 2023-06-30 | $1.11B 10-Q · filed 2023-10-18 | $2.21B 10-Q · filed 2024-07-17 | $3.14B derived: sum of 3 quarters · filed 2025-02-20 | $4.05B derived: sum of 4 quarters · filed 2025-02-20 | |||
| 2023-03-31 | $1.10B 10-Q · filed 2024-04-18 | $2.03B derived: sum of 2 quarters · filed 2025-02-20 | $2.94B derived: sum of 3 quarters · filed 2025-02-20 | $4.10B derived: sum of 4 quarters · filed 2025-02-20 | |||
| 2022-12-31 | $926.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $1.84B derived: sum of 2 quarters · filed 2025-02-20 | $3.00B derived: sum of 3 quarters · filed 2025-02-20 | $4.10B 10-K · filed 2025-02-20 | |||
| 2022-09-30 | $910.00M 10-Q · filed 2023-10-18 | $893.00M 10-Q · filed 2022-10-19 | $2.07B derived: sum of 2 quarters · filed 2023-10-18 | $3.17B 10-Q · filed 2023-10-18 | $3.12B 10-Q · filed 2022-10-19 | ||
| 2022-06-30 | $1.16B 10-Q · filed 2023-10-18 | $1.14B 10-Q · filed 2022-07-20 | $2.26B 10-Q/A · filed 2023-09-29 | $2.23B 10-Q · filed 2022-07-20 | |||
| 2022-03-31 | $1.10B 10-Q · filed 2023-10-18 | $1.08B 10-Q · filed 2022-04-20 | |||||
| 2021-09-30 | $941.00M 10-Q · filed 2022-10-19 | $1.86B derived: sum of 2 quarters · filed 2022-10-19 | $2.83B 10-Q · filed 2022-10-19 | ||||
| 2021-06-30 | $919.00M 10-Q · filed 2022-10-19 | $1.89B 10-Q · filed 2022-07-20 | |||||
| 2021-03-31 | $972.00M 10-Q · filed 2022-10-19 | ||||||
| 2020-09-30 | $922.00M 10-Q · filed 2021-10-20 | $1.72B derived: sum of 2 quarters · filed 2021-10-20 | $2.68B 10-Q · filed 2021-10-20 | ||||
| 2020-06-30 | $799.00M 10-Q · filed 2021-10-20 | $1.76B 10-Q · filed 2021-07-21 | |||||
| 2020-03-31 | $959.00M 10-Q · filed 2021-10-20 | ||||||
| 2019-09-30 | $856.00M 10-Q · filed 2020-10-28 | $1.74B derived: sum of 2 quarters · filed 2020-10-28 | $2.68B 10-Q · filed 2020-10-28 | ||||
| 2019-06-30 | $884.00M 10-Q · filed 2020-10-28 | $1.83B 10-Q · filed 2020-07-29 | |||||
| 2019-03-31 | $943.00M 10-Q · filed 2020-10-28 | ||||||
| 2018-09-30 | $774.00M 10-Q · filed 2019-10-23 | $404.00M 10-Q · filed 2018-10-31 | $1.58B derived: sum of 2 quarters · filed 2019-10-23 | $2.42B 10-Q · filed 2019-10-23 | $1.25B 10-Q · filed 2018-10-31 | ||
| 2018-06-30 | $805.00M 10-Q · filed 2019-10-23 | $424.50M 10-Q · filed 2018-07-25 | $1.65B 10-Q · filed 2019-07-24 | $844.40M 10-Q · filed 2018-07-25 | |||
| 2018-03-31 | $842.00M 10-Q · filed 2019-10-23 | $420.00M 10-Q · filed 2018-04-25 | |||||
| 2017-09-30 | $400.00M 10-Q · filed 2018-10-31 | $399.80M 10-Q · filed 2017-10-25 | $755.60M derived: sum of 2 quarters · filed 2018-10-31 | $1.13B 10-Q · filed 2018-10-31 | $1.12B 10-Q · filed 2017-10-25 | ||
| 2017-06-30 | $355.60M 10-Q · filed 2018-07-25 | $724.50M 10-Q · filed 2018-07-25 | |||||
| 2017-03-31 | $368.90M 10-Q · filed 2018-04-25 | ||||||
| 2016-09-30 | $329.80M 10-Q · filed 2017-10-25 | $634.30M derived: sum of 2 quarters · filed 2017-10-25 | $947.90M 10-Q · filed 2017-10-25 | ||||
| 2016-06-30 | $304.50M 10-Q · filed 2017-07-26 | $618.10M 10-Q · filed 2017-07-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |